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RNA-binding proteins (RBPs) regulate splicing according to position-dependent principles, which can be exploited
for analysis of regulatory motifs. Here we present RNAmotifs, a method that evaluates the sequence around
differentially regulated alternative exons to identify clusters of short and degenerate sequences, referred to as
multivalent RNA motifs. We show that diverse RBPs share basic positional principles, but differ in their propensity to
enhance or repress exon inclusion. We assess exons differentially spliced between brain and heart, identifying
known and new regulatory motifs, and predict the expression pattern of RBPs that bind these motifs. RNAmotifs is
available at https://bitbucket.org/rogrro/rna_motifs.Background
The majority of human genes produce multiple mRNA
isoforms via the process of alternative splicing [1]. Alter-
native splicing is regulated mainly by RNA-binding pro-
teins (RBPs), which often act according to positional
principles defined by an RNA splicing map to enhance
or repress exon inclusion [2,3]. These RBPs play key
roles in development and evolution, and mutations per-
turbing protein-RNA interactions can lead to a variety of
diseases [4,5]. Therefore, to infer the splicing regulatory
programs and identify new disease-causing mutations,
algorithms are required that can assess the genomic se-
quence at the differentially regulated exons to predict
the RNA motifs bound by these RBPs.
Great progress has been made over the past decade in
inferring the programs of splicing regulation [1]. However,
it is not yet clear which positional principles of splicing
regulation are shared between different RBPs. The sites of
protein-RNA interactions have been defined by different
crosslinking and immunoprecipitation (CLIP) methods
(HITS-CLIP, PAR-CLIP or iCLIP), but the differences be-
tween these methods preclude precise comparisons be-
tween the RNA maps that were derived for the different
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reproduction in any medium, provided the oraffected by mild sequence biases [6]; thus, it is important
to develop methods that can derive the regulatory motifs
independently of the CLIP data. Therefore, a new compu-
tational method is required to derive RNA maps solely
from the analysis of gene expression data.
Past studies that predicted splicing regulatory motifs from
analysis of the differentially regulated exons searched for
continuous motifs, which most often identified UGCAUG
as the most frequent motif [7-15]. This sequence is recog-
nized by RNA binding protein, fox-1 homologs 1 and 2
(RBFOX1 and RBFOX2), splicing regulators that recognize
three nucleotides via the canonical RNA binding surface
and an additional four nucleotides via the loops of a quasi-
RRM (qRRM) domain [16]. However, RBFOX proteins are
exceptional in their ability to recognize a long continuous
motif, and most other splicing regulators recognize motifs
that are only three or four nucleotides long [17,18].
Studies of neuro-oncological ventral antigen 1 and 2
(NOVA1 and NOVA2), here collectively referred to as
NOVA proteins, demonstrated that three or more short
RNA motifs that are clustered closely together on the
pre-mRNA are required for NOVA proteins to mediate
splicing regulation [2]. Here we will refer to these motifs
as 'multivalent RNA motifs', since they enable RBPs to
achieve high-affinity binding by cooperative interactions
between multiple RNA-binding domains and the clustered
short RNA motifs [17,18]. Past computational methods
for analysis of multivalent RNA motifs have focused onLtd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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based on the CLIP studies of protein-RNA interactions
[17,18]. However, a method for de novo identification of
multivalent RNA motifs by analysis of the regulated exons
is not yet available.
Here, we present RNAmotifs, a method that identifies
clusters of short non-degenerate (ND) or degenerate (DG)
tetramers that are enriched at specific positions around
the enhanced and silenced exons. The method correctly
identified the multivalent RNA motifs bound by NOVA,
PTBP1, heterogeneous nuclear ribonucleoprotein C
(hnRNP C), TARDBP, and TIA1 and TIAL1 cytotoxic
granule-associated RNA binding proteins (here collect-
ively referred to as TIA proteins). Moreover, RNAmotifs
determines the RNA splicing map, which enabled us to
compare the positional principles of different RBPs. Fi-
nally, we analyzed the exons that are differentially spliced
between brain and heart, identifying new candidate motifs
responsible for tissue-specific splicing regulation. Notably,
we demonstrate that the positional enrichment informa-
tion of the RNA splicing map can be used to predict the
tissue where the candidate regulatory protein that binds
each RNA motif is more highly expressed.
Results
Identification of multivalent regulatory motifs
In recent years, exon and splice junction microarray and
RNAseq studies have identified groups of exons that are
differentially regulated in specific tissues and diseases or
at specific developmental stages [1]. In spite of the abun-
dance of expression data, it remains challenging to iden-
tify the transacting factors that control splicing of the
differentially regulated exons. Here we exploited the
clustering property of regulatory motifs to develop RNA-
motifs, a method for de novo identification of multiva-
lent regulatory motifs. We considered tetramers as the
core motifs, assuming that most RNA-binding domains
recognize up to four nucleotides [17]. We evaluated 64
DG tetramers, where purine R(A/G) or pyrimidine Y(C/
T) transitions were allowed at the boundary nucleotides,
such as in the YCAY tetramer. The degeneracy was
allowed because several RBPs tolerate purine or pyrimi-
dine transitions in their target motifs [17,20-23]. To
identify multivalent motifs, we assessed if the motifs
were clustered with spacing of up to 15 nucleotides,
which we chose based on previous studies of PTBP1 and
NOVA motif spacing [21,24].
We evaluated the genomic sequence at three regions
around the splice sites of the regulated exons (Figure 1).
These regions were defined based on the RNA splicing
map of NOVA proteins, which has been determined by
the positioning of conserved YCAY clusters as well as by
the binding sites identified by HITS-CLIP [2,14,25]. We
analyzed tetramer clusters in these regions by evaluatingenrichment in enhanced and silenced exons, compared to
control exons. Each region in enhanced and silenced
exons was evaluated separately, because RBPs generally
bind at different positions when they enhance or silence
exon inclusion [3]. We determined region-specific enrich-
ment of each motif using Fisher’s exact test, corrected this
for multiple testing, and calculated the achieved signifi-
cance level of the test using a bootstrapping procedure.
We first analyzed the exons regulated by NOVA to iden-
tify the NOVA RNA splicing map. Our approach differed
from previous studies [2,25] since we did not predefine
the sequence specificity of NOVA, consider motif conser-
vation, or use CLIP data. We analyzed the 98 enhanced,
70 silenced and 4,200 control exons that were identified
by the splice junction microarray study of NOVA2−/−
mouse brain neocortex [25] (Additional file 1). Our
method identified 14 tetramers enriched at the NOVA-
regulated exons (Figure 2; Additional file 2). For the pur-
pose of comparative analysis, tetramers were grouped
based on similarity in their sequence. YCAY was the top-
ranking tetramer, and 8 of the 14 tetramers enriched
at NOVA target exons were part of the YCAY group
(Figure 2), in agreement with in vitro studies that identi-
fied YCAY as the core NOVA-binding motif. All 14 motifs
were found significantly enriched upstream of silenced
exons, except for TCTC, which was enriched upstream of
enhanced exons. YCAY was also enriched within silenced
exons and downstream of enhanced exons.
We next assessed how the enriched tetramers are
precisely positioned in the RNA splicing map. We deter-
mined the enrichment score (ES) at nucleotide reso-
lution and plotted color-coded RNA splicing maps,
where blue and red colors represent splicing silencer or
enhancer motifs, respectively. The RNA splicing maps
showed that the seven tetramers that are part of the
YCAY group were enriched at similar positions: down-
stream of the enhanced exons, and upstream of the si-
lenced exons (Figure 2). These positions were consistent
with the map defined originally based on the analysis of
conserved YCAY clusters [2]. Importantly, YCAY identi-
fied a more complete set of enriched positions compared
to the ND tetramers (Figure 2). This result indicates that
analysis of DG tetramers can improve the comprehen-
sive identification of splicing regulatory motifs.
Comparative analysis of RNA splicing maps of diverse RBPs
In order to compare the regulatory properties of multiple
RBPs in an unbiased manner, we collected data from mul-
tiple studies that have used Affymetrix AltSplice exon
junction microarrays to evaluate splicing changes that take
place upon knockout or knockdown of an RBP [10,26-28].
RNAmotifs predicted multivalent RNA motifs that agree
with the RNA specificity defined for the assessed proteins
in the past studies.
Figure 1 Flowchart describing the steps used by RNAmotifs to identify the enriched multivalent RNA motifs. The multivalent RNA motifs
are predicted by assessing clusters of tetramers that are enriched in the genomic sequence at specific positions relative to enhanced or silenced exons,
compared to control exons. Clusters of each tetramer are evaluated in three regions around the splice sites of alternative exons. Analysis of control exons
is used to determine the clustering threshold that each tetramer needs to reach before it is considered as a ‘cluster instance’. A one-tailed Fisher’s exact
test is then used to test the null hypothesis that the number of cluster instances at a precise region of a particular tetramer is not different between
enhanced (or silenced) and control exons, and the Benjamini-Hochberg false discovery rate (FDR) correction is applied to calculate pfdr. For each tetramer,
the achieved significance level of the test (pempirical) is calculated with a bootstrap procedure using 10,000 samples. Tetramers with pfdr ≤0.1 and pempirical
≤0.0005 in at least one region either in the enhanced or silenced set are retained (Additional file 2). The RNA map is then drawn to visualize the
enrichment score at each nucleotide around the enhanced or silenced exons, and their flanking exons. nts, nucleotides; ss, splice site.
Cereda et al. Genome Biology 2014, 15:R20 Page 3 of 12
http://genomebiology.com/2014/15/1/R20The top ranking tetramers predicted for hnRNP C
(TTTT and YTTY) were enriched at the 3′ splice sites and
in a more widespread region downstream of the silenced
exons (Figure 3a), in agreement with the RNA map that
was defined based on iCLIP data [26]. Moreover, we identi-
fied three additional tetramers with lower enrichment
(AGTG, CCTC, CCAC), which most likely correspond to
motifs that are common at the Alu-derived exons that are
regulated by hnRNP C [29]. The top ranking tetramers
predicted for PTB (YTCY and YCTY) were enriched at the
3′ splice sites of the silenced exons (Figure 3b), in agree-
ment with the known PTBP1 binding to TC-rich motifsupstream of the silenced exons [10,30]. A lower enrich-
ment of TC-rich motifs was also observed downstream of
enhanced exons (Figure 3b; Additional files 2 and 3), which
is consistent with the previous finding that PTBP1 can en-
hance splicing when binding downstream of alternative
exons [10]. The top ranking TARDBP tetramer (RTGY)
was enriched at the 3′ splice sites of the silenced exons
(Figure 3c), in agreement with the RNA map that was de-
fined based on iCLIP data [27]. Finally, the top ranking
TIA tetramers (TTTA, TTAT) were enriched downstream
of the enhanced exons (Figure 4), again in agreement with
the RNA map that was defined based on iCLIP data [28].
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Figure 2 RNA splicing map of multivalent RNA motifs enriched at NOVA target exons. Sequences of the enriched tetramers are shown on
the left, followed by a color-coded panel showing the regions where tetramer enrichment reached the defined threshold around silenced (blue)
or enhanced (red) exons. The gray panel marks the tetramers that overlap in their sequence (marked in the same shade of grey), and the right
panel depicts the nucleotide-resolution RNA splicing map of each motif at the enhanced or silenced exons, and their flanking exons. The color
key indicates whether the position-specific contribution originates from enhanced (E; red), silenced (S; blue), or both (yellow) sets. The maximum
enrichment score (ES) value of the top tetramer, which is used to plot all tetramers, is reported on the right. Nt, nucleotides.
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the sequence specificity determined by past studies, in-
cluding the observation that PTBP1 and TARDBP can
tolerate pyrimidine or purine transitions in their binding
sites [21-23,26,28,30,31]. We also identified other motifs
less enriched at exons regulated by these proteins, which
will not be discussed here, but could be used for future
studies of cooperative splicing regulation (Figures 2, 3, 4,
5 and 6; Additional files 2, 3 and 4). Most importantly,
by deriving RNA splicing maps for five distinct RBPs, we
could perform an unbiased comparison of their pos-
itional splicing effects. NOVA proteins are unique in
their ability to repress and enhance exon inclusion to
the same extent, since a similar extent of motif enrich-
ment is seen at both types of exons. The RNA splicing
map of PTBP1 is most similar to that of NOVA, con-
taining motif enrichment at 3′ splice sites of silenced
exons and downstream of enhanced exons, but the en-
richment at silenced exons is more dominant in the case
of PTBP1. In the case of hnRNP C and TDP-43, the
motif enrichment is restricted to the silenced exons, and
in the case of TIA, it is largely restricted to the enhanced
exons. Nevertheless, the similarity in motif positions
suggests that all the assessed proteins repress or enhance
exon inclusions from roughly the same positions as
NOVA proteins; instead, the differences between theRNA splicing maps of RBPs reflect their variable extent
of splicing repression compared with enhancement.
Co-regulation of alternative exons
YCAY and related tetramers were the most enriched at
the exons regulated by NOVA. Nevertheless, three other
groups of tetramers were also identified as significantly
enriched in NOVA target exons. Of these, the TCTC motif
is of particular interest, since it is bound by PTBP1 and
PTBP2 (Figure 2). Importantly, this motif was enriched in
a reciprocal pattern compared to the PTBP1 RNA map.
Rather than being enriched at the 3′ splice sites of silenced
exons, it was enriched at the 3′ splice sites of exons that
are enhanced by NOVA. To assess the relationship be-
tween the YCAY and TCTC motifs, we evaluated the
exons showing instances of these tetramers in r1, r2 or r3
regions of interest (see Materials and methods). We iden-
tified five exons enhanced by NOVA, which had a YCAY
cluster downstream of the 5' splice site (r3) as well as a
TCTC cluster upstream of the 3' splice site (r1) (Additional
file 5). This number of enhanced exons having both types
of motifs in the regions of interest was significantly
higher compared to the control exons (P = 0.0026, Fish-
er’s exact test). Since PTBP1 is a potent repressor of
neuron-specific splicing [32], it is likely that these
exons are silenced by PTBP1 in non-neuronal cells, and
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Figure 3 RNA splicing map of multivalent RNA motifs for RBPs that predominantly repress splicing. The RNA splicing maps are shown as
described in Figure 2 for the following proteins: (A) hnRNP C, (B) PTBP1, (C) TDP-43. The 10 top ranking motifs are shown for hnRNP C and
PTBP1. Nt, nucleotides.
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crease the fidelity of their brain-specific splicing pat-
tern. This finding demonstrates that RNAmotifs can be
used to study co-regulation of alternative exons by
RBPs that bind to multivalent regulatory motifs.
Identification of multivalent motifs mediating tissue-specific
alternative splicing
In addition to defining the RNA splicing maps by ana-
lysis of exons that change their splicing after removal of
a single RBP, we also tested the ability of RNAmotifs to
identify regulatory motifs from more complex datasets.
Initially, we prepared a dataset where we mixed the al-
ternative exons regulated by hnRNP C, PTBP1 and TIA
proteins. We considered exons as differentially expressed
if they were in the enhanced or silenced group for any
of these proteins, and considered exons as controls if
they were regulated by none of these three proteins.Interestingly, in spite of analyzing these mixed data, the
eight top-ranking tetramers included the motifs bound
by hnRNP C, PTBP1, and TIA proteins (TTTT, YTCY
and TTTA, respectively). Furthermore, the three distinct
groups of tetramers were correctly separated (TT-rich,
TC-rich and TA-rich), and were enriched at the same
positions in the RNA splicing maps as in the analysis of
unmixed data (Figure 5). This result demonstrates that
our algorithm can be applied to studies of complex data-
sets, which include exons regulated by multiple RBPs.
Tissue-specific patterns of alternative splicing are a result
of combinatorial actions of multiple RBPs that are differen-
tially expressed between these tissues. We used Affymetrix
AltSplice splice junction microarrays to identify alternative
exons that are differentially spliced between adult human
brain and heart tissues, and used RNAmotifs to identify
regulatory motifs that contribute to the splicing differences.
Following the principles of the RNA map, we expected that
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Figure 4 RNA splicing map of multivalent RNA motifs for TIA1/TIAL1 that predominantly enhance splicing. The RNA splicing map is
shown as described in Figure 2 for TIA1/TIAL1, showing the 10 top ranking motifs. Nt, nucleotides.
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to motifs enriched in r1 and r2 of exons silenced in the
brain, and/or in r3 of exons enhanced in the brain (see
Materials and methods). This identified seven motifs that
were enriched upstream of silenced exons and one (ATCT)
enriched downstream of enhanced exons (Figure 6a). The
top ranking tetrameres were YATY, CATT, TCAT, which
all correspond to the YCAY motif bound by NOVA. The
other top ranking tetramer was YTTR, which corresponds
to the binding motif of ELAV3, a neuron-specific RBP that
binds to uridine tracts that are interrupted by a single G or
A [33]. Conversely, RBPs that are more highly expressed in
the heart would be expected to bind motifs enriched in r1
and r2 of exons enhanced in the brain, and/or in r3 of
exons silenced in the brain. We identified 17 tetramers that
were enriched upstream of enhanced exons, the top-
ranking of which were TC-rich tetramers that were identi-
cal to those enriched in the PTBP1 RNA map (Figures 2
and 6b). We could not identify candidate RBPs thatYTAY
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YTTY
TTTT
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Figure 5 RNA splicing maps of multivalent RNA motifs enriched in th
The RNA splicing map is shown as described in Figure 2 for the mixed datrecognize the remaining identified motifs; therefore, these
could be a basis for future studies. In summary, our predic-
tions agree with past studies showing that NOVA and
ELAV3 are expressed in neurons to promote brain-specific
splicing, whereas PTBP1 is expressed outside brain to op-
pose neuron-specific splicing patterns [32]. Thus, in
addition to identifying the regulatory motifs, the RNA
maps can also predict the tissue where the candidate RBPs
binding to these motifs are more highly expressed.
Discussion
In this study, we have developed and evaluated RNAmo-
tifs software to identify multivalent RNA motifs from
analysis of differentially regulated exons. Multivalency
plays a pivotal role in biological recognition [34], and its
role has been well explored in ubiquitin signaling [35]
and in the extracellular matrix [36]. Here we explore the
importance of this concept for RNA regulation, and con-
firm that multivalent RNA motifs mediate the position-0
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Figure 6 RNA splicing maps of multivalent RNA motifs enriched at the exons differentially spliced between adult brain and heart. The RNA
splicing maps are shown as described in Figure 2 for a comparison between adult brain and heart splicing. (A) Tetramers enriched at positions
corresponding to the standard pattern of RNA maps (enrichment in r1 and r2 of exons silenced in the brain, and/or in r3 of exons enhanced in the brain).
These tetramers are predicted to be bound by RBPs with higher expression in the brain compared with the heart. (B) The 10 top ranking tetramers
enriched at positions corresponding to the reciprocal pattern of RNA maps (enrichment in r1 and r2 of exons enhanced in the brain, and/or in r3 of exons
silenced in the brain). These tetramers are predicted to be bound by RBPs with higher expression in the heart compared to the brain. Nt, nucleotides.
Cereda et al. Genome Biology 2014, 15:R20 Page 7 of 12
http://genomebiology.com/2014/15/1/R20dependent splicing regulation. Even though we used no
experimental evidence on the sequence specificity of dif-
ferent proteins, RNAmotifs generated RNA splicing
maps that were similar to those previously defined by
CLIP [10,25-28]. The method does not require analysis
of sequence conservation and can therefore identify
species-specific regulatory sites. Finally, we used our ap-
proach to identify multivalent RNA motifs that mediate
tissue-specific splicing regulation. Importantly, the most
enriched motifs correspond to binding sites of NOVA,
ELAV3 and PTBP1 proteins, and the positions of motif
enrichment in the RNA splicing map agree with the
higher expression of NOVA and ELAV3 in the brain
[20,33], and PTBP1 in other tissues [32].
A comparison of the RNA splicing maps shows that all
of the five RBPs silence exon inclusion mainly when bind-
ing upstream or within the exons, and enhance inclusion
when binding only downstream of exons. However, the
RBPs differ in the frequency of their functional binding
sites at the different positions of the RNA splicing map.
The positions of motif enrichment demonstrate thathnRNP C and TARDBP almost exclusively repress exon
inclusion, whereas TIA proteins enhance exon inclusion
when binding proximally to the exons. Only the motifs
bound by NOVA and PTBP1 are enriched both at en-
hanced and silenced exons, but in the case of PTBP1, the
enrichment is more significant at the repressed exons.
Thus, NOVA seems quite unique in its capacity to directly
repress or enhance inclusion of a similar number of exons.
Analysis of DG motifs generated a more comprehen-
sive RNA splicing map for NOVA, TDP-43 and PTBP1
compared to ND motifs. This is most clear in the case of
NOVA proteins, where only the analysis of YCAY motifs
identified the full spectrum of known positions where
NOVA proteins regulate splicing (upstream of and
within silenced exons, and downstream of enhanced
exons). The ND motifs show biases for specific posi-
tions; for instance, CCAT clusters are primarily enriched
downstream of enhanced exons, and TCAT clusters are
enriched upstream of silenced exons. We propose that
these positional biases may relate to the other proteins
that can bind at the same positions. NOVA may compete
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U2AF65 preferentially binds to uridine; therefore, enrich-
ment of a uridine-rich TCAT motif at 3′ splice sites may
allow U2AF65 to initiate exon inclusion in non-neuronal
tissues [37]. In contrast, the exons enhanced by NOVA
should not be enhanced by other exons outside the brain,
in order to ensure their brain-specific splicing pattern.
Therefore, a cytosine-rich CCAT motif downstream of
enhanced exons may prevent TIA proteins from bind-
ing and initiating exon inclusion in non-neuronal tis-
sues. Thus, the DG binding motif may allow NOVA to
adjust the sequence of its binding sites depending on
other proteins that can act at the same positions in the
RNA splicing map, which could contribute to NOVA’s
capacity to either repress or enhance exon inclusion.
Our results support coordinate regulation of exons by
multiple RBPs. We identified several exons containing
both TCTC and YCAY clusters, indicating reciprocal regu-
lation by PTB and NOVA proteins. The TCTC cluster re-
sembles the binding site of PTBP1 and PTBP2. PTBP1 is a
potent repressor of neuron-specific splicing in non-
neuronal cells [32]; therefore, the reciprocal regulation of
exons by NOVA and PTBP1 could enhance the fidelity of
neuron-specific splicing. Moreover, PTBP2 is a neuronal
protein that was shown to antagonize the splicing activity
of NOVA on GlyRalpha2 pre-mRNA [14,38]. Since
PTBP2 represses adult-specific splicing in neuronal pre-
cursors, the reciprocal regulation by NOVA and PTBP2
could ensure that the exons reach their brain-specific pat-
tern in the adult, but not embryonic brain [39].
Conclusions
RNAmotifs provides a publicly available tool to identify
regulatory motifs from analysis of co-regulated alterna-
tive exons. We demonstrate how analysis of multivalent
RNA motifs and their precise positions can facilitate the
prediction of regulatory motifs from splice junction
microarray data. RNAmotifs can be readily combined
with RNAseq data to assess differentially regulated exons
or alternative polyadenylation sites. If combined with
additional elements, such as conservation, CLIP binding,
RNA structure and analysis of non-clustered contiguous
motifs, analysis of multivalent RNA motifs could be fur-
ther integrated into studies of tissue-specific splicing and
the RNA splicing code [7].
Materials and methods
RNAmotifs software employs the GeCo++ library [40] and
the R statistical software [41]. It is freely available via a Bit-
bucket repository at [42]. The repository includes the proc-
essed microarray data that can be used to replicate the
results of this study, together with automated scripts that
download and prepare the genomic sequence, search for
tetramers in splicing regions and compute other analysissteps. Documentation about installing and running the
software is available in the README file. The unprocessed
cel files of brain and heart splice junction microarray data
are available from ArrayExpress with accession number E-
MTAB-1911. The microarray data from previous studies
that were used here is available from ArrayExpress with ac-
cession numbers E-MTAB-527, E-MTAB-526, E-MTAB-
367, E-GEOD-12965 and E-GEOD-23513.
Microarray data
The present study analyzed regulatory motifs at exons iden-
tified by Affymetrix AltSplice exon junction microarray ex-
periments from this study and previously published studies.
These include analysis of NOVA1/NOVA2 knockout mouse
brain, and knockdown of hnRNPC, PTBP1, TPD-43 or TIA
in human cell lines [10,25-28]. The total adult human brain
or adult human heart RNAs were obtained from BioChain
and evaluated in triplicates using the same procedure as de-
scribed previously [27]. The microarray data were analyzed
using ASPIRE version 3 [26]. By analyzing the signal of re-
ciprocal probe sets, ASPIRE3 was able to monitor splicing
of 18,531 and 9,103 alternative cassette exons (CEs) for hu-
man and mouse arrays, respectively. Then, for each RBP,
we divided CEs into three sets according to the dIRank: en-
hanced (dIRank >1), silenced (dIRank < −1) and control
exons (| dIRank | <0.1) (Additional file 1). Exon coordinates
were retrieved from the UCSC annotation database [43],
using the mm9 assembly for mouse and the hg19 assembly
for the human exons.
Definition of multivalent motifs
To define and identify the multivalent motifs, we evalu-
ated three regions around the alternative CEs, which
were selected based on the past studies of the Nova
RNA splicing map [2]: first, region r1 [−35:-5] nucleo-
tides of intronic sequence upstream of the 3′ splice site;
second, region r2 of exonic sequence [1:31] nucleotides
downstream of the 3′ splice site and [−31:-1] nucleotides
upstream of the 5′ splice site (if exon is shorter than 61
nucleotides, then evaluate the whole exon); third, region
r3 [10:40] nucleotides of intronic sequence downstream
of the 5′ splice site (Figure 1).
Since most RNA-binding motifs recognize up to four
nucleotides [19], we considered tetramers as our core
motifs. Several RBPs tolerate purine or pyrimidine tran-
sitions at some positions of their target motifs [17,22,44]
so we included 64 DG tetramers in addition to 256 ND
tetramers. The 64 DG tetramers were defined such that
the central two nucleotides were ND (A,C,G,T), whereas
the nucleotides at the boundary could be either purines
R(A/G) or pyrimidines Y(C/T), such as in the YCAY
tetramer. Thus, each DG tetramer included four ND tet-
ramers. For example, YCAY included instances of TCAT,
TCAC, CCAT and CCAC tetramers. We allowed overlap
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the sequence (see example below).
We first identified all nucleotides that overlapped with
each tetramer, which we refer to as 'tetramer nucleotides'.
As the aim of our analysis was to account for the ability of
RBPs to bind multiple proximal motifs (that is, multivalent
motifs), we determined the 'cluster height' (h) as the num-
ber of 'tetramer nucleotides' within a 31 nucleotide win-
dow centered on each evaluated position; h was assigned
only to positions directly overlapping a tetramer (see the
example below). Hence, h ranged from a minimum of 4 to
a maximum of 31 (4 ≤ h ≤ 31). We analyzed the h value for
all tetramers at each nucleotide in the sequence surround-
ing all monitored CEs and their flanking exons.
We retrieved 500 nucleotides of flanking intronic se-
quence next to each splice site (or up to the middle if the
intron is shorter than 1 kb), and 100 nucleotides of exonic
sequence next to each splice site (or up to the middle if
the exon is shorter than 200 nucleotides) and determined
the percentage of genomic sequence (named 'coverage
percentage') covered by each tetramer. For each tetramer,
we then selected the minimum h (hmin) corresponding to
the coverage percentage closest to 0.5% and then consid-
ered all nucleotide positions with h ≥ hmin as having the
'cluster instance'. This definition of minimum h was made
in order to take into account the variation in the occur-
rence and clustering of different tetramers. To determine
the optimal hmin, we analyzed the sequences in the regions
r1, r2 and r3 surrounding the NOVA-regulated enhanced,
silenced and control exons, and determined the coverage
percentage covered by each h for the YCAY tetramer. We
assessed the h with coverage percentages closest to 0.062,
0.125, 0.25, 0.5, and 1, and the results of this analysis are
shown in Additional file 6. A coverage percentage of 0.5%
is the minimum required to detect >10% of the regulated
exons in each of the regions in a correct manner: that is,
silenced exons in regions 1 and 2, and enhanced exons in
region 3. After identifying the hmin with a coverage per-
centage closest to 0.5% for each tetramer, we considered
all nucleotide positions with h ≥ hmin as having the 'cluster
instance'. In this way, we ensured that the probability of
a cluster instance with the chosen hmin was similar for
all tetramers.
The following example shows the search for the YCAY
motif cluster with an hmin of 9 for an arbitrary sequence:The first line shows the genomic sequence, the second
line marks the positions overlapping YCAY tetramers,
the third line shows the h values, and the last line the
positions of the cluster instance. We repeated the ana-
lysis for all selected exons and collected the cluster in-
stances of all tetramers.
Identification of enriched multivalent motifs
To identify the multivalent motifs that occurred in a
specific region more often in the regulated exons com-
pared with control exons, we used the following proced-
ure. If any nucleotide sequence included a tetramer with
a cluster instance 1 within the region, then the region
was given the value of 1, otherwise 0. We then calcu-
lated the significance of tetramer enrichment in each of
these regions at all enhanced or silenced exons, com-
pared with controls. Formally, let T = {t1, t2, …, t320} rep-
resent tetramers to be analyzed, and R = {r1, r2, r3} be the
set of regions of interest. For each group of exons (en-
hanced, silenced and controls), we generated a regional-
specific occurrences matrix M= {RxT}, with three rows
and T columns. Each cell M(r,t) represents the sum of
values for all exons of the corresponding region ri and
tetramer tj. To evaluate the statistical significance of the
region-specific enrichment of each tetramer, we used a
one-tailed Fisher’s exact test to test the null hypothesis
that the number of cluster instances at a region ri of a
tetramer tj is not different between enhanced (or si-
lenced) and control exons. A hypothetical example re-
ported in Table 1 shows the test made for a specific
region ri and tetramer tj, assuming that the sum of
values is 30 for a total of 98 enhanced exons and 300 for
a total of 4,200 control exons. The resulting P-value for
this example is 6.695 × 10-12.
The result of this analysis was two matrices F (en-
hanced and silenced, respectively) with three rows and T
columns of P-values representing tetramer enrichments
in each region. These P-values were corrected for mul-
tiple testing relative to the number of tested tetramers
(320 in this case) using the Benjamini-Hochberg false
discovery rate correction to obtain pfdr.
We next calculated the achieved significance level of the
Fisher’s exact test using a bootstrap procedure (pempirical),
representing the probability of observing at least that large
a value when the null hypothesis is true. pempirical was
Table 1 An example of the values used for the Fisher's exact test of tetramer enrichment
tj Menhanced(ri,tj) Mcontrol(ri,tj) Total
Number of exons with tetramer tj Present 30 300 330
Absent 98-30 4,200-300 4,298-330
Total 98 4,200 4,298
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Bootstrap samples were generated by random selection
with replacement of the enhanced, silenced and control
exons. For each bootstrap sample, the same procedure as
described above (including false discovery rate correction)
was used to estimate the statistical significance of region-
specific tetramer enrichment (pbootstrap). The achieved sig-
nificance of tetramer enrichment was estimated by:
pempirical ri; tj
  ¼
1þ# pbootstrap ri; tj
 
< pfdr ri; tj
  
1þ#bootstrap
For subsequent analyses we retained tetramers that
passed the threshold pfdr ≤ 0.1 and pempirical ≤ 0.0005 in
any of the three regions, as described below:
pfdr r1; tj
 
≤0:1ANDpempirical r1; tj
 
≤0:0005
 h i
OR pfdr r2; tj
 
≤0:1 AND pempirical r2; tj
 
≤0:0005
 h i
OR pfdr r3; tj
 
≤0:1 AND pempirical r1; tj
 
≤0:0005
 h i
We evaluated tetramer enrichment in the enhanced and
silenced set independently of each other. The tetramers
that passed the threshold are reported in Additional files
2, 3 and 4. These tetramers were studied with the further
steps, ending with the RNA map visualization.
Nucleotide-resolution RNA maps of motif enrichment
To visualize the precise positions in the pre-mRNA
where clusters are enriched, we performed a position-
specific enrichment analysis at positions corresponding
to the exon-intron and intron-exon junctions of alterna-
tive CEs and flanking exons extending 200 nucleotides
into introns and 50 nucleotides into exons. If the intron
or exon were shorter than 400 or 100 nucleotides, re-
spectively, we evaluated the sequence as far as the mid-
dle of the intron or exon. In these regions, we
determined the positions of cluster instances for all tet-
ramers. Formally, let T = {t1, t2, …, t320} represent tetra-
mers to be analyzed and let P = {p1, p2, …, p1000} be the
set of positions of interest (250 nucleotides for each of
the four considered junctions). For each group of exons
(enhanced, silenced and controls), we generated a
positional-specific occurrences matrix M= {PxT}, with P
rows and T columns. Each cell M(p,t) represents the
number of cluster instances at position pi of the tetra-
mer tj. To evaluate statistical significance of position-specific enrichment of each tetramer, we used a Fisher’s
exact test to test the null hypothesis that the number of
cluster instances at a position pi of a tetramer tj is not
different between enhanced (or silenced) and control
exons. The result of this analysis was two matrices F
(enhanced and silenced, respectively) with P rows and T
columns of position-specific P-values representing tetra-
mer enrichments.
We next evaluated the position-specific occurrences of
each tetramer at two distinct sets of exons (that is, en-
hanced and silenced exons). We used the Fisher’s
method [45] to combine the two independent tests into
one goodness-of-fit (Χ2) statistic, referred to as the en-
richment score (ES). The ES of each selected tetramer at
each position in the regions of interest was calculated
using the following formula:
ES p; jð Þ ¼ −2  log F p; jð ÞEnchanced
 þ log F p; jð ÞSilenced
  
with {p ∈ P} (positions) and {j ∈ T: pempirical ≤ α} (selected
tetramers).
For alternative exons, ES allows evaluation of the joint
enrichment at enhanced and silenced exons. To visualize
the splicing regulatory activity of each tetramer at en-
hanced and silenced exons separately, we then used the
RNA splicing maps as described below.
Tetramers were grouped on the basis of sequence
composition and ES profile. For each tetramer we calcu-
lated the cumulative sum of ES over the positions. We
next aligned the remaining tetramers to the one with the
highest cumulative sum, and whenever the alignment of
another tetramer matched three consecutive nucleotides,
it was grouped together with the top tetramer. We re-
cursively repeated the procedure on non-aligned tetra-
mers until all were part of 'groups'. In the case of DG
motifs, the alignment of each motif was performed using
the four ND sequences composing the motif and requir-
ing at least two ND sequences to be aligned. Within
each group, tetramers were sorted on the basis of the
Pearson’s correlation of their enrichment profile with the
top scored tetramers of the group.
We visualized the RNA splicing maps by plotting the
ES profiles over the region of interest (Figure 1). All
RNA maps display the enrichment score normalized to
the maximum value in the ES matrix. In cases where
more than 10 tetramers were retained with the pfdr ≤0.1
and pempirical ≤0.0005 threshold (Additional file 4), the
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ramers with the highest maximum ES values. The color
key indicates the contribution of enhanced (red = 100%),
silenced (blue = 100%) or both (yellow = 50%) sets of
exons to the position-specific enrichment of a tetramer.
Thus, the RNA map does not exclude examples where
both enhanced and silenced exons are enriched at the
same position; whereas red and blue show motifs
enriched only at enhanced or silenced exons, positions
where motifs are enriched in both sets of exons are
shown in yellow.Additional files
Additional file 1: Evaluation of the NOVA target exons identified
when different 'coverage percentages' are chosen for the definition
of YCAY clusters. This figure shows the analysis that was used to
determine the appropriate hmin. We retrieved 500 nucleotides of flanking
intronic sequence next to each splice site (or up to the middle if the
intron is shorter than 1 kb), and 100 nucleotides of exonic sequence next
to each splice site (or up to the middle if the exon is shorter than 200
nucleotides) and determine the percentage of genomic sequence
(termed 'coverage percentage') covered by each tetramer. To determine
the optimal hmin, we analyzed the sequences in the regions r1, r2 and r3,
and determined the coverage percentage for each h for the YCAY
tetramer. The percentage of NOVA-regulated enhanced, silenced and
control exons that contained the YCAY tetramer differed when choosing
the coverage percentage closest to 0.062, 0.125, 0.25, 0.5, and 1, as shown
separately for each region in the three graphs. As shown in the table,
0.5% is the minimum coverage percentage required to detect >10% of
the regulated exons in each of the regions in a correct manner: that is,
silenced exons in regions 1 and 2, and enhanced exons in region 3.
Additional file 2: Tetramers found enriched in at least one dataset.
This figure shows tetramers that have been found significantly enriched
(pdfr <0.1 and pempirical <0.0005) in at least one dataset (NOVA, hnRNP C,
PTBP1, TARDBP, TIAL1, 'Mixed' and Brain-Heart sets) in the region of interest
surrounding the cassette exons. Tetramers enriched in enhanced exons are
depicted in blue, whereas those enriched in silenced exons are in red.
Additional file 3: Table showing the number of regulated and
control cassette exons for each RNA-binding protein. The 'Mixed'
dataset contains exons that are differentially regulated by hnRNP C, PTB
or TIA proteins. For this set, we considered only exons showing the same
regulatory activity with the three proteins. No overlap between
enhanced, silenced and control exons was allowed. (XLS 405 kb)
Additional file 4: Table showing results of enrichment analysis of
tetramer clusters at exons regulated by different RBPs. Each line
shows the tetramer, its pfdr, and pempirical obtained from 10,000 bootstrap
samples for the three region of interest. Each sheets reports data for a
specific data set (NOVA, hnRNP C, PTBP1, TARDBP, TIAL1, 'Mixed' and
Brain-Heart sets).
Additional file 5: Table showing tetramers found as significantly
enriched. Each line reports an enriched tetramer for an exon type
(enhanced, silenced), the regions where it was found as significantly
enriched, the corresponding pfdr, and pempirical obtained from 10,000
bootstrap samples for the three regions of interest in a specific data set
(NOVA, hnRNP C, PTBP1, TARDBP, TIAL1, 'Mixed' and Brain-Heart sets).
Additional file 6: Table showing Nova-targeted exons co-regulated
by PTBP1. The table reports exons that show instances of both YCAY
and TCTC clusters.Abbreviations
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